30 November 1999
Antiretroviral therapy and its influence on the stage of brain damage in patients with HIV – 1H MRS evaluation
Eugeniusz Tarasów, Alicja Wiercińska-Drapało, Jerzy Jaroszewicz, Agnieszka Orzechowska-Bobkiewicz, Wojciech Dzienis, Danuta Prokopowicz, Jerzy WaleckiMed Sci Monit 2004; 10(3): 101-106 :: ID: 878557
Abstract
Background: MR proton spectroscopy (1H MRS) enables early detection of metabolic changes, which occur in the course of AIDS Dementia Complex Syndrome (ADC). The goal of the study was the evaluation of highly active antiretroviral therapy (HAART) and its influence on the character and intensity of metabolic changes in brain 1H MRS spectra in clinically asymptomatic HIV-infected patients as well as search for correlation between the treatment and 1H MR spectroscopy results and immune deficit degree.
Material and Methods: In the group of 20 HIV+ patients, the examination of the central nervous system (CNS), MR and 1H MRS were conducted twice: before HAART treatment and during the therapy; on average after 6 months (4–9 months of treatment).
Results: The levels of NAA/Cr in the control MRS examination were close to the values observed before treatment. However, statistically significant increase in NAA/Cho ratio (p<0.05) was noticed. The control examination showed statistically decrease of Cho/Cr and mI/Cr ratios, though statistically insignificant (p>0.05). NAA and Cr contents in reference to the signal of non-suppressed water increased insignificantly in the follow-up examination. However, statistically significant decrease in Cho/H2O and mI/H2O levels (p<0.05) was observed.
Conclusion: The therapy with HAART affects normalization of metabolite levels in the central nervous system in clinically asymptomatic HIV+ patients and diminishes the risk of ADC occurrence. Myoinositol and choline levels estimated in 1H MRS might be the indices for antiretroviral treatment efficacy.
Keywords: highly active retroviral therapy, brain damage, MR spectroscopy, AIDS Dementia Complex - pathology, Antiretroviral Therapy, Highly Active, Aspartic Acid - metabolism, Choline - metabolism, Creatine - metabolism, Inositol - metabolism, Magnetic Resonance Spectroscopy - methods
Editorial
01 June 2025 : Editorial
Editorial: Harmonization and Publication of the 2025 Updates of the CONSORT and SPIRIT Statements for Clinical TrialsDOI: 10.12659/MSM.949923
Med Sci Monit 2024; 31:e949923
In Press
Clinical Research
Comparative Analysis of Oxidative Stress Biomarkers in 50 Primary Open-Angle Glaucoma PatientsMed Sci Monit In Press; DOI: 10.12659/MSM.948665
Review article
Linking Triglyceride-Glucose Index to Spontaneous Intracerebral Hemorrhage: Mechanisms and Predictive InsightsMed Sci Monit In Press; DOI: 10.12659/MSM.948695
Clinical Research
Comparative Spectrophotometric Assessment of Crown Discoloration from Diverse Endodontic SealersMed Sci Monit In Press; DOI: 10.12659/MSM.947874
Clinical Research
Ultrasound Measurement of Pupillary Dilation Reflex During Induction of General Anesthesia Using Sufentanil...Med Sci Monit In Press; DOI: 10.12659/MSM.948209
Most Viewed Current Articles
17 Jan 2024 : Review article 9,044,913
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 704,022
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 32,751
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 26,945
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912